NVO
$NVO
Novo Nordisk A/S
Danish pharma giant behind Ozempic and Wegovy weight-loss treatments.
Healthcare$36.97
+0.49 (+1.34%)
Day Range$35.63 - $36.98
Prev Close$36.48
Analyst Rating
Hold
12 Buy / 23 Hold / 2 Sell
Subscribers
1
Tracking this ticker
Next Report
Sun, Apr 5
Weekly updates
Latest Report
NVO: Valuation Reset Amid Demand Shift
Novo Nordisk ($NVO) is trading at deeply discounted multiples and a high dividend yield following a sharp re-rating. Fundamentals remain strong, but weakening obesity drug demand and data inconsistencies leave the outlook mixed.
Mar 30, 2026